Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026)
Fortrea Holdings (FTRE) posted Operating Expenses of $639.9 million for Q1 2026, down 5.07% on a QoQ basis from $674.1 million in Q4 2025, and down 45.37% year-over-year from $1.2 billion in Q1 2025.
Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026) Analysis & Trends
Fortrea Holdings' Operating Expenses history runs 5 years deep, the most recent figure standing at $639.9 million for Q1 2026.
- Quarterly Operating Expenses fell 45.37% year-over-year to $639.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 billion (down 7.98% YoY) and the FY2025 annual result came in at $3.6 billion, up 25.81% from the prior year.
- Operating Expenses was $639.9 million for Q1 2026 at Fortrea Holdings, down from $674.1 million in the prior quarter.
- Across five years, Operating Expenses topped out at $1.2 billion in Q1 2025 and bottomed at $488.3 million in Q4 2022.
- A 5-year average of $738.0 million and a median of $701.5 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2025 — Operating Expenses jumped 67.46% — and 2026, when it sank 45.37%.
- Fortrea Holdings' Operating Expenses stood at $488.3 million in 2022, then soared by 50.26% to $733.7 million in 2023, then rose by 2.58% to $752.6 million in 2024, then dropped by 10.43% to $674.1 million in 2025, then fell by 5.07% to $639.9 million in 2026.
- Business Quant data shows FTRE's Operating Expenses at $639.9 million in Q1 2026, $674.1 million in Q4 2025, and $709.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | 639.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 639.90 Mn |
| Dec 31, 2025 | 674.10 Mn |
| Sep 30, 2025 | 709.90 Mn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.17 Bn |
| Dec 31, 2024 | 752.60 Mn |
| Sep 30, 2024 | 692.90 Mn |
| Jun 30, 2024 | 713.30 Mn |
| Mar 31, 2024 | 699.50 Mn |
| Dec 31, 2023 | 733.70 Mn |
| Sep 30, 2023 | 703.50 Mn |
| Jun 30, 2023 | 693.50 Mn |
| Mar 31, 2023 | 679.80 Mn |
| Dec 31, 2022 | 488.30 Mn |
| Sep 30, 2022 | 693.40 Mn |
| Jun 30, 2022 | 721.90 Mn |